Logo image of BLCO.CA

BAUSCH + LOMB CORP (BLCO.CA) Stock Fundamental Analysis

TSX:BLCO - Toronto Stock Exchange - CA0717051076 - Common Stock - Currency: CAD

19  -0.34 (-1.76%)

Fundamental Rating

4

Overall BLCO gets a fundamental rating of 4 out of 10. We evaluated BLCO against 15 industry peers in the Health Care Equipment & Supplies industry. While BLCO is still in line with the averages on profitability rating, there are concerns on its financial health. BLCO has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

6

1. Profitability

1.1 Basic Checks

BLCO had positive earnings in the past year.
BLCO had a positive operating cash flow in the past year.
In multiple years BLCO reported negative net income over the last 5 years.
Of the past 5 years BLCO 4 years had a positive operating cash flow.
BLCO.CA Yearly Net Income VS EBIT VS OCF VS FCFBLCO.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M 600M 800M

1.2 Ratios

BLCO has a better Return On Assets (-2.70%) than 100.00% of its industry peers.
Looking at the Return On Equity, with a value of -5.69%, BLCO belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
With an excellent Return On Invested Capital value of 0.78%, BLCO belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for BLCO is in line with the industry average of 0.78%.
Industry RankSector Rank
ROA -2.7%
ROE -5.69%
ROIC 0.78%
ROA(3y)-1.41%
ROA(5y)-0.54%
ROE(3y)-2.87%
ROE(5y)-1.37%
ROIC(3y)1.45%
ROIC(5y)1.75%
BLCO.CA Yearly ROA, ROE, ROICBLCO.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 2 -2 -4

1.3 Margins

BLCO's Operating Margin of 2.63% is amongst the best of the industry. BLCO outperforms 100.00% of its industry peers.
In the last couple of years the Operating Margin of BLCO has declined.
Looking at the Gross Margin, with a value of 60.03%, BLCO is in the better half of the industry, outperforming 73.33% of the companies in the same industry.
BLCO's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 2.63%
PM (TTM) N/A
GM 60.03%
OM growth 3Y-22.07%
OM growth 5Y-17.92%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.06%
GM growth 5Y-1.25%
BLCO.CA Yearly Profit, Operating, Gross MarginsBLCO.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

More info and screens

2

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so BLCO is destroying value.
Compared to 1 year ago, BLCO has more shares outstanding
Compared to 5 years ago, BLCO has more shares outstanding
The debt/assets ratio for BLCO is higher compared to a year ago.
BLCO.CA Yearly Shares OutstandingBLCO.CA Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 100M 200M 300M
BLCO.CA Yearly Total Debt VS Total AssetsBLCO.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

BLCO has an Altman-Z score of 0.81. This is a bad value and indicates that BLCO is not financially healthy and even has some risk of bankruptcy.
BLCO's Altman-Z score of 0.81 is amongst the best of the industry. BLCO outperforms 86.67% of its industry peers.
A Debt/Equity ratio of 0.75 indicates that BLCO is somewhat dependend on debt financing.
The Debt to Equity ratio of BLCO (0.75) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.75
Debt/FCF N/A
Altman-Z 0.81
ROIC/WACC0.11
WACC7.26%
BLCO.CA Yearly LT Debt VS Equity VS FCFBLCO.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B

2.3 Liquidity

A Current Ratio of 1.56 indicates that BLCO should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.56, BLCO is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
A Quick Ratio of 0.96 indicates that BLCO may have some problems paying its short term obligations.
BLCO has a Quick ratio (0.96) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 1.56
Quick Ratio 0.96
BLCO.CA Yearly Current Assets VS Current LiabilitesBLCO.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

More info and screens

4

3. Growth

3.1 Past

The earnings per share for BLCO have decreased strongly by -32.39% in the last year.
BLCO shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 11.94%.
Measured over the past years, BLCO shows a small growth in Revenue. The Revenue has been growing by 4.87% on average per year.
EPS 1Y (TTM)-32.39%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-200%
Revenue 1Y (TTM)11.94%
Revenue growth 3Y8.36%
Revenue growth 5Y4.87%
Sales Q2Q%3.46%

3.2 Future

Based on estimates for the next years, BLCO will show a very strong growth in Earnings Per Share. The EPS will grow by 24.11% on average per year.
BLCO is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.45% yearly.
EPS Next Y-20.51%
EPS Next 2Y12.29%
EPS Next 3Y19.54%
EPS Next 5Y24.11%
Revenue Next Year5.41%
Revenue Next 2Y5.44%
Revenue Next 3Y5.22%
Revenue Next 5Y4.45%

3.3 Evolution

The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
BLCO.CA Yearly Revenue VS EstimatesBLCO.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2B 4B 6B
BLCO.CA Yearly EPS VS EstimatesBLCO.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0.5 1 1.5 2

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 28.79 indicates a quite expensive valuation of BLCO.
Based on the Price/Earnings ratio, BLCO is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
Compared to an average S&P500 Price/Earnings ratio of 27.41, BLCO is valued at the same level.
With a Price/Forward Earnings ratio of 17.74, BLCO is valued on the expensive side.
Compared to the rest of the industry, the Price/Forward Earnings ratio of BLCO indicates a rather cheap valuation: BLCO is cheaper than 93.33% of the companies listed in the same industry.
BLCO's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 35.19.
Industry RankSector Rank
PE 28.79
Fwd PE 17.74
BLCO.CA Price Earnings VS Forward Price EarningsBLCO.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

100.00% of the companies in the same industry are more expensive than BLCO, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 17.05
BLCO.CA Per share dataBLCO.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20

4.3 Compensation for Growth

BLCO has a very decent profitability rating, which may justify a higher PE ratio.
BLCO's earnings are expected to grow with 19.54% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y12.29%
EPS Next 3Y19.54%

More info and screens

0

5. Dividend

5.1 Amount

BLCO does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BAUSCH + LOMB CORP

TSX:BLCO (7/11/2025, 7:00:00 PM)

19

-0.34 (-1.76%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)04-30 2025-04-30/bmo
Earnings (Next)07-30 2025-07-30/bmo
Inst Owners10.83%
Inst Owner ChangeN/A
Ins Owners0.45%
Ins Owner ChangeN/A
Market Cap6.72B
Analysts72.63
Price Target20.64 (8.63%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-178.13%
Min EPS beat(2)-360.35%
Max EPS beat(2)4.09%
EPS beat(4)3
Avg EPS beat(4)-86.35%
Min EPS beat(4)-360.35%
Max EPS beat(4)6.68%
EPS beat(8)6
Avg EPS beat(8)-34.35%
EPS beat(12)9
Avg EPS beat(12)-16.97%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-1.61%
Min Revenue beat(2)-3.07%
Max Revenue beat(2)-0.16%
Revenue beat(4)1
Avg Revenue beat(4)-0.35%
Min Revenue beat(4)-3.07%
Max Revenue beat(4)1.93%
Revenue beat(8)4
Avg Revenue beat(8)1.13%
Revenue beat(12)7
Avg Revenue beat(12)0.92%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.77%
PT rev (3m)-25.02%
EPS NQ rev (1m)-10.16%
EPS NQ rev (3m)-54.06%
EPS NY rev (1m)-1.7%
EPS NY rev (3m)-27.55%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.7%
Revenue NY rev (1m)0.02%
Revenue NY rev (3m)0.65%
Valuation
Industry RankSector Rank
PE 28.79
Fwd PE 17.74
P/S 1.02
P/FCF N/A
P/OCF 29.56
P/B 0.77
P/tB N/A
EV/EBITDA 17.05
EPS(TTM)0.66
EY3.47%
EPS(NY)1.07
Fwd EY5.64%
FCF(TTM)-0.65
FCFYN/A
OCF(TTM)0.64
OCFY3.38%
SpS18.7
BVpS24.63
TBVpS-6.32
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.7%
ROE -5.69%
ROCE 1.09%
ROIC 0.78%
ROICexc 0.8%
ROICexgc 2.61%
OM 2.63%
PM (TTM) N/A
GM 60.03%
FCFM N/A
ROA(3y)-1.41%
ROA(5y)-0.54%
ROE(3y)-2.87%
ROE(5y)-1.37%
ROIC(3y)1.45%
ROIC(5y)1.75%
ROICexc(3y)1.5%
ROICexc(5y)1.8%
ROICexgc(3y)4.98%
ROICexgc(5y)6.16%
ROCE(3y)2.02%
ROCE(5y)2.43%
ROICexcg growth 3Y-21.86%
ROICexcg growth 5Y-17.06%
ROICexc growth 3Y-20.45%
ROICexc growth 5Y-15.79%
OM growth 3Y-22.07%
OM growth 5Y-17.92%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.06%
GM growth 5Y-1.25%
F-Score3
Asset Turnover0.36
Health
Industry RankSector Rank
Debt/Equity 0.75
Debt/FCF N/A
Debt/EBITDA 8.57
Cap/Depr 77.31%
Cap/Sales 6.92%
Interest Coverage 250
Cash Conversion 29.7%
Profit Quality N/A
Current Ratio 1.56
Quick Ratio 0.96
Altman-Z 0.81
F-Score3
WACC7.26%
ROIC/WACC0.11
Cap/Depr(3y)53.43%
Cap/Depr(5y)52.81%
Cap/Sales(3y)5.03%
Cap/Sales(5y)5.53%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-32.39%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-200%
EPS Next Y-20.51%
EPS Next 2Y12.29%
EPS Next 3Y19.54%
EPS Next 5Y24.11%
Revenue 1Y (TTM)11.94%
Revenue growth 3Y8.36%
Revenue growth 5Y4.87%
Sales Q2Q%3.46%
Revenue Next Year5.41%
Revenue Next 2Y5.44%
Revenue Next 3Y5.22%
Revenue Next 5Y4.45%
EBIT growth 1Y-42.79%
EBIT growth 3Y-15.55%
EBIT growth 5Y-13.93%
EBIT Next Year40.8%
EBIT Next 3Y21.5%
EBIT Next 5Y15.15%
FCF growth 1Y-244.83%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-41.96%
OCF growth 3Y-35.71%
OCF growth 5Y-21.91%